Indium (111 In) Uses, Dosage, Side Effects and more
Indium (111 In) is under investigation in clinical trial NCT00493454 (Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas).
| Trade Name | Indium (111 In) |
| Generic | Indium In-111 |
| Indium In-111 Other Names | Indium (111 In) |
| Type | |
| Formula | In |
| Weight | Average: 110.9051 Monoisotopic: 110.905110677 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
